These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
894 related articles for article (PubMed ID: 26947959)
1. Synthesis, structural characterization, docking, lipophilicity and cytotoxicity of 1-[(1R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]-3-alkyl carbamates, novel acetylcholinesterase and butyrylcholinesterase pseudo-irreversible inhibitors. Pejchal V; Štěpánková Š; Pejchalová M; Královec K; Havelek R; Růžičková Z; Ajani H; Lo R; Lepšík M Bioorg Med Chem; 2016 Apr; 24(7):1560-72. PubMed ID: 26947959 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro evaluation of new derivatives of 2-substituted-6-fluorobenzo[d]thiazoles as cholinesterase inhibitors. Imramovský A; Pejchal V; Štěpánková Š; Vorčáková K; Jampílek J; Vančo J; Šimůnek P; Královec K; Brůčková L; Mandíková J; Trejtnar F Bioorg Med Chem; 2013 Apr; 21(7):1735-48. PubMed ID: 23462716 [TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization and in vitro evaluation of substituted N-(2-phenylcyclopropyl)carbamates as acetyl- and butyrylcholinesterase inhibitors. Horáková E; Drabina P; Brož B; Štěpánková Š; Vorčáková K; Královec K; Havelek R; Sedlák M J Enzyme Inhib Med Chem; 2016; 31(sup3):173-179. PubMed ID: 27476673 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of novel carbamates as potential inhibitors of acetylcholinesterase and butyrylcholinesterase. Wu J; Pistolozzi M; Liu S; Tan W Bioorg Med Chem; 2020 Mar; 28(5):115324. PubMed ID: 32008882 [TBL] [Abstract][Full Text] [Related]
5. Novel carbamate derivatives as selective butyrylcholinesterase inhibitors. Bajda M; Łątka K; Hebda M; Jończyk J; Malawska B Bioorg Chem; 2018 Aug; 78():29-38. PubMed ID: 29529519 [TBL] [Abstract][Full Text] [Related]
6. Novel Benzene-Based Carbamates for AChE/BChE Inhibition: Synthesis and Ligand/Structure-Oriented SAR Study. Bak A; Kozik V; Kozakiewicz D; Gajcy K; Strub DJ; Swietlicka A; Stepankova S; Imramovsky A; Polanski J; Smolinski A; Jampilek J Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934674 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, molecular docking and molecular dynamics studies of novel tacrine-carbamate derivatives as potent cholinesterase inhibitors. Ozten O; Zengin Kurt B; Sonmez F; Dogan B; Durdagi S Bioorg Chem; 2021 Oct; 115():105225. PubMed ID: 34364052 [TBL] [Abstract][Full Text] [Related]
8. Proline-Based Carbamates as Cholinesterase Inhibitors. Pizova H; Havelkova M; Stepankova S; Bak A; Kauerova T; Kozik V; Oravec M; Imramovsky A; Kollar P; Bobal P; Jampilek J Molecules; 2017 Nov; 22(11):. PubMed ID: 29135926 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase. Ghafary S; Ghobadian R; Mahdavi M; Nadri H; Moradi A; Akbarzadeh T; Najafi Z; Sharifzadeh M; Edraki N; Moghadam FH; Amini M Daru; 2020 Dec; 28(2):463-477. PubMed ID: 32372339 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization, and molecular docking analysis of novel benzimidazole derivatives as cholinesterase inhibitors. Yoon YK; Ali MA; Wei AC; Choon TS; Khaw KY; Murugaiyah V; Osman H; Masand VH Bioorg Chem; 2013 Aug; 49():33-9. PubMed ID: 23886696 [TBL] [Abstract][Full Text] [Related]
11. Methyl analogues of the experimental Alzheimer drug phenserine: synthesis and structure/activity relationships for acetyl- and butyrylcholinesterase inhibitory action. Yu Q; Holloway HW; Flippen-Anderson JL; Hoffman B; Brossi A; Greig NH J Med Chem; 2001 Nov; 44(24):4062-71. PubMed ID: 11708910 [TBL] [Abstract][Full Text] [Related]
12. Lead optimization studies towards the discovery of novel carbamates as potent AChE inhibitors for the potential treatment of Alzheimer's disease. Roy KK; Tota S; Tripathi T; Chander S; Nath C; Saxena AK Bioorg Med Chem; 2012 Nov; 20(21):6313-20. PubMed ID: 23026084 [TBL] [Abstract][Full Text] [Related]
13. Discovery of Highly Selective and Nanomolar Carbamate-Based Butyrylcholinesterase Inhibitors by Rational Investigation into Their Inhibition Mode. Sawatzky E; Wehle S; Kling B; Wendrich J; Bringmann G; Sotriffer CA; Heilmann J; Decker M J Med Chem; 2016 Mar; 59(5):2067-82. PubMed ID: 26886849 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, structure-activity relationship and molecular docking of 3-oxoaurones and 3-thioaurones as acetylcholinesterase and butyrylcholinesterase inhibitors. Mughal EU; Sadiq A; Murtaza S; Rafique H; Zafar MN; Riaz T; Khan BA; Hameed A; Khan KM Bioorg Med Chem; 2017 Jan; 25(1):100-106. PubMed ID: 27780618 [TBL] [Abstract][Full Text] [Related]
15. Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies. Mutahir S; Jończyk J; Bajda M; Khan IU; Khan MA; Ullah N; Ashraf M; Qurat-ul-Ain ; Riaz S; Hussain S; Yar M Bioorg Chem; 2016 Feb; 64():13-20. PubMed ID: 26595185 [TBL] [Abstract][Full Text] [Related]
16. Novel alkyl- and arylcarbamate derivatives with N-benzylpiperidine and N-benzylpiperazine moieties as cholinesterases inhibitors. Więckowska A; Bajda M; Guzior N; Malawska B Eur J Med Chem; 2010 Dec; 45(12):5602-11. PubMed ID: 20926161 [TBL] [Abstract][Full Text] [Related]